TrialClinical colorectal cancer2014

Ganetespib, a novel Hsp90 inhibitor in patients with KRAS mutated and wild type, refractory metastatic colorectal cancer.

Andrea Cercek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.